Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nuvo Pharmaceuticals Inc (MRV.TO)

Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuvo Pharmaceuticals Inc 6733 Mississauga Road Suite 800 Mississauga ON L5N 6J5 CAN

https://www.miravohealthcare.com P: 905-673-6980 F: 905-673-1842

Description:

Nuvo Pharmaceuticals Inc doing business as Miravo Healthcare which is a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquires growth-oriented, complementary products for Canadian and international markets.

Key Statistics

Overview:

Market Capitalization, $K 15,374
Shares Outstanding, K 11,388
Annual Sales, $ 68,907 K
Annual Net Income, $ -32,205 K
Last Quarter Sales, $ 18,119 K
Last Quarter Net Income, $ 447 K
60-Month Beta 0.92
% of Institutional Shareholders 1.84%

Growth:

1-Year Return 3.05%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 20.57%

Per-Share Information:

Latest Earnings Date 03/27/23
Earnings Per Share ttm -0.07
EPS Growth vs. Prev Qtr -99.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-65 on 05/09/13

MRV.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 1,180.47%
Return-on-Assets % 11.57%
Profit Margin % -46.74%
Debt/Equity N/A
Price/Sales 0.49
Price/Book 1.81
Book Value/Share 0.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar